Navigation Links
New Anti-Rejection Medication 6-Month Results for Heart Transplant,Recipients to Be Released at International Heart and Lung,Transplant Meeting

ADDISON, Texas, April 19, 2007 /PRNewswire/ -- New clinical trial results for heart transplant patients will be released at the upcoming International Society for Heart and Lung Transplantation (ISHLT) 27th Annual Meeting and Scientific Sessions at the Hilton San Francisco, April 25-28, 2007. Results show promise for efficacy and safety of immunosuppression therapy and lower incidences of acute organ rejection in heart transplants.

    Research to be presented includes:

    --  Six Month Data on Cyclosporine Reduction and Impact on Renal Function

        with Everolimus In De Novo Heart Transplant Recipients will be

        presented Wednesday, April 25 during a luncheon symposium at 12:30pm

        PDT.

    --  6 Month Data from a 12 Month Study of Everolimus with Reduced

        Cyclosporine Exposure vs. MMF and Conventional Cyclosporine in De Novo

        Heart Transplant Recipients will be presented during the same luncheon

        symposium on April 25.

The leading cause of death during the first year following heart transplant is acute rejection of the transplanted organ. The patient's immune system attacks the heart as if it were a foreign object until it no longer functions properly. The one-year survival rate after transplantation is approximately 80 percent; this number drops to nearly 50 percent after 10 years.

About ISHLT

The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit organization dedicated to the advancement of the science and treatment of end-stage heart and lung diseases. Created in 1981, the Society now includes more than 2,200 members from 45-plus countries, representing a variety of disciplines involved in the management and treatment of end-stage heart and lung disease.

ISHLT manages two vital databases. The International Heart and Lung Registry is a one-of-a-kind registry that has been collecting data since 1983 from 223 hospitals from 18 countries. The ISHLT Mechanical Circulatory Device (MCSD) database has been collecting data since 2002 with the aim of identifying patient populations who may benefit from MCSD implantation, generating predictive models for outcomes; and assessing the mechanical and biological reliability of current and future devices. In Fall 2006, ISHLT released the first international guidelines for heart failure patient management. For more information, visit http://www.ishlt.org.

Contact: Lauren Mason

              (210) 731-6646

              


lmason@masonpr.com

CONTACT: Lauren Mason, +1-210-731-6646, , forInternational Society for Heart and Lung Transplantation lmason@masonpr.com

Web site: http://www.ishlt.org/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
2. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
3. New Data Focuses on Abuse of Stimulant Medication
4. Separate Sets of Research Show Treatment Improved Quality of Life in as Early as Three Weeks; Patient Adherence to Medication is Multifactorial
5. FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications
6. Survey: Migraine Patients Taking Potentially Addictive Barbiturate or Opioid Medications Not Approved by FDA as Migraine Treatments
7. Drug for Treatment of Heart Failure Does Not Improve Survival, Compared to More Widely-used Medication
8. Study Sheds Light on Medication Treatment Options for Bipolar Disorder
9. Stanford Study Finds No Conclusive Benefit From Treating Kleptomania With Medication
10. Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
11. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... 23, 2017 ArisGlobal, a leading ... announces agClinical 3.3, the latest version of its comprehensive ... science organizations to confidently and efficiently meet new compliance ... the electronic trial master file so that compliance is ... ...
(Date:1/23/2017)... , Jan. 23, 2017 Endo International ... Trade Commission (FTC) today filed a joint motion in ... California seeking the entry of ... Order resolves all disputes between the FTC and Endo ... in connection with its Opana® ER and Lidoderm® products.  ...
(Date:1/23/2017)... CLARA, Calif. , Jan. 23, 2017 /PRNewswire/ ... protection market, Frost & Sullivan recognizes Ansell, a ... Global Frost & Sullivan Company of the Year ... customer-centric approach, and a wide global footprint have ... in the hand protection market. The Company,s established ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... , ... “Choosing Wisdom-Solomon’s Proverbs Reclaimed”: an inspiring collection ... adultery, anger, and common sense. , “Choosing Wisdom-Solomon’s Proverbs Reclaimed” is the ... In September of 1983, they flew to Haiti to focus on missions work. ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... use to improve the connection with God. “Spiritual Vitamins: A Spiritual Energy Booster” ... Published by Christian Faith Publishing, Mathai Yohannan’s new book engages the mind and ...
(Date:1/24/2017)... ... January 24, 2017 , ... “The Octagon of Spiritual Balances”: ... Spiritual Balances” is the creation of published author, Pastor Bernard J. Weathers, pastor of ... a bachelor degree in religious education and a master degree in theology. , ““The ...
(Date:1/24/2017)... ... January 24, 2017 , ... Attention women ... article suggests that autologous fat grafting—taking one’s own fat and putting it ... breast implants. , Cosmetic Surgeon and Medical Director of MilfordMD Cosmetic Dermatology ...
(Date:1/24/2017)... ... January 23, 2017 , ... ... on Friday, January 20, with the bipartisan original co-sponsorship of nearly one-quarter of ... January 12. The National Association of Chain Drug Stores (NACDS) strongly backs the ...
Breaking Medicine News(10 mins):